Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 63, Issue 6, 2000, Pages 329-335

  Koba, S ^a,b   Pakala, R ^a   Watanabe, T ^b   Katagiri, T ^b   Benedict, C R ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; THROMBOXANE A2;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA DETERMINATION; DNA SYNTHESIS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RABBIT; RESTENOSIS; SMOOTH MUSCLE FIBER;

ORYCTOLAGUS CUNICULUS;

EID: 0034491136     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2000.0223     Document Type: Article

References (42)

1. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease
2. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
3. Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia
4. Mechanisms of restenosis and redilation with coronary stents; quantitative angiographic assessment
5. Oxidation modification of LDL and atherosclerosis
6. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
7. The oxidation hypothesis of atherosclerosis
8. The sphingomyelin-ceramide signaling pathway is involved in oxidatized low density lipoprotein-induced cell proliferation
9. Atherosclerosis: Basic mechanisms oxidation, inflammation, and genetics
10. Vascular smooth muscle proliferation: Synergistic interaction between serotonin and low density lipoproteins
11. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis
12. Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells
13. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression
14. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: Role of arachiodonic acid
15. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal
16. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides
17. 2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits
18. 2 and the specific antagonists on vascular smooth muscle cell proliferation
19. Thromboxane and vascular smooth muscle cell growth in genetically hypertensive rats
20. 2 in vascular smooth muscle cells
21. 2 and vascular smooth muscle cell proliferation
22. 2-stimulated mitogenesis of coronary smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase
23. 2
24. Novel 21-Aminosteroid like compounds prevent iron-induced free radical-mediated injury to vascular endothelial cells
25. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells
26. The role of oxidized low-density lipoprotein in atherogenesis
27. Role of oxidized low density lipoprotein in atherosclerosis
28. Methods for determination of aldehydic lipid peroxidation products
29. Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration
30. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages
31. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle cells
32. Frequency and severity of cyclic flow alterations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury
33. 2 receptors
34. MAP Kinase Pathways
35. New insights into the control of MAP kinase pathways
36. The MAP kinase cascade
37. Nuclear export of the stress-activated protein kinase p39 mediated by its substrate MAPKAP kinase-2
38. Stress-activated protein kinases: Activation, regulation and function
39. The role of protein phosphatases in the regulation of mitogen and stress-activated protein kinases
40. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades
41. Platelet activation by low density lipoprotein and serotonin: Effects of calcium antagonist
42. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins